Skip to content
Certified ManufacturersFor manufacturers

Country Life, LLC

Hauppauge, NY, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Country Life, LLC is a dietary supplement manufacturer in Hauppauge, NY, United States, certified to NSF/ANSI 455-2 GMP, with 2 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. It is also a USDA Organic certified operation. Listed dosage forms: capsules, gummies, liquids, oils, powders, softgels and tablets.

Facilities listed
4
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Products on its USDA Organic certificate

Product types among the organic items that Country Life, LLC’s certified operation lists in the USDA Organic Integrity Database.

USDA Organic Integrity Database, operation 5520066579, checked .

These are organic items only: the certificate says nothing about the company’s non-organic products. A listed item is the certifier’s record of what the operation is certified to handle organically, not a test of the product. About USDA Organic item lists

Certified facilities

Manufacturing (2)

  • 180 Motor Parkway, Hauppauge, NY 11788, United States

    • Coating
    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing
  • 500 Commack Rd., Commack, NY 11725, United States

    • Warehousing

Distribution (2)

  • 9401 Diamond Drive, North Little Rock, AR 72117, United States

    • Warehousing
  • 101 Corporate Drive, Hauppauge, NY 11788, United States

How Country Life, LLC compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

FDA lists 1 recall matching the name Country Life, LLC, as of .

  • Class II · Could cause temporary or reversible health problems

    Reported

    Closed by FDA

    The affected lots do not meet quality standards due to insoluble particulates.

    Product: Country Life TARGET MINS CALCIUM MAGNESIUM With Vitamin D3 Complex, WILD BLUEBERRY FLAVOR, LIQUID Dietary Supplement, 16 FL. OZ. (1 PINT) (472 mL), Product No.…

    Full product description
    • Country Life TARGET MINS CALCIUM MAGNESIUM With Vitamin D3 Complex, WILD BLUEBERRY FLAVOR, LIQUID Dietary Supplement, 16 FL. OZ. (1 PINT) (472 mL), Product No. 2523, Bar Code 015794025238, and 32 FL. OZ. (1 QT) (944 mL), Product No. 2522, Bar code 015794025221 --- Manufactured for Country Life, LLC 180 Vanderbilt Motor Parkway, Hauppauge, NY 11788
    openFDA record

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 7 food or dietary supplement inspections at facilities matching Country Life, LLC, from 2012 to 2024, as of . 1 found no objectionable conditions and 6 found conditions the firm was left to correct.

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    11 citations posted:

    • Personnel - hygienic practices (21 CFR 111.10(b))
    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - contamination limits (21 CFR 111.70(b)(3))
    See all 11 citations
    • Personnel - hygienic practices (21 CFR 111.10(b))

      Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.

    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength and composition.

    • Specifications - contamination limits (21 CFR 111.70(b)(3))

      You did not establish limits for contamination that may adulterate or may lead to adulteration of the finished dietary supplement.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the strength of the finished dietary supplement.

    • Tests, examinations - scientifically valid (21 CFR 111.75(h))

      You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.

    • Master manufacturing record theoretical and expected yield (21 CFR 111.210(f))

      Your master manufacturing record did not include a statement of the theoretical yield for each point, step, or stage of the manufacturing process to ensure quality control.

    • Instructions; specifications; packaged, labeled (21 CFR 111.210(h)(1))

      The written instructions in your master manufacturing record did not include specifications for each point, step, or stage in the manufacturing process where control is necessary to ensure that the dietary supplement is packaged and labeled as specified in the master manufacturing record.

    • Master manufacturing record - sampling, tests, examinations (21 CFR 111.210(h)(2))

      The written instructions in your master manufacturing record did not include procedures for sampling and a cross-reference to procedures for tests or examinations.

    • Batch record - initials; each step (21 CFR 111.260(j)(2))

      Your batch production records did not include initials of the persons performing each step.

    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))

      You held components, dietary supplements and labels under conditions that lead to mix-up, contamination, or deterioration.

    FEI 2432499

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    1 citation posted:

    • Manufacturing operations - prevent contamination (21 CFR 111.365)
    Full citation text
    • Manufacturing operations - prevent contamination (21 CFR 111.365)

      You did not take necessary precautions during the manufacture of a dietary supplement to prevent contamination of dietary supplements.

    FEI 2432499

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    4 citations posted:

    • Documentation - equipment functions; intended use (21 CFR 111.35(b)(6))
    • Criteria for establishing specifications (21 CFR 111.315(a))
    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))
    • Record - person document; time of performance (21 CFR 111.570(b)(2)(i))
    Full citation text
    • Documentation - equipment functions; intended use (21 CFR 111.35(b)(6))

      You did not make and keep documentation of the controls you use to ensure that equipment functions according to its intended use.

    • Criteria for establishing specifications (21 CFR 111.315(a))

      You did not establish and follow laboratory control processes for use of criteria for establishing appropriate specifications.

    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))

      You held components under conditions that lead to mix-up, contamination, or deterioration.

    • Record - person document; time of performance (21 CFR 111.570(b)(2)(i))

      The person who performed a requirement relating to product complaints did not document, at the time of performance, that the requirement was performed.

    FEI 2432499

  • No action indicated · No objectionable conditions found

    Inspected

    Hauppauge, New York

    FEI 2432499

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    8 citations posted:

    • Gloves (21 CFR 111.10(b)(5))
    • Hand-washing facilities (21 CFR 111.15(i))
    • Floors, walls, ceilings (21 CFR 111.20(d)(1)(i))
    • Equipment - automated - QC check (21 CFR 111.30(c))
    See all 8 citations
    • Gloves (21 CFR 111.10(b)(5))

      Your personnel used gloves that were not in a sanitary condition.

    • Hand-washing facilities (21 CFR 111.15(i))

      Your hand-washing facilities are not adequate and are not convenient.

    • Floors, walls, ceilings (21 CFR 111.20(d)(1)(i))

      Your ceilings were not designed and constructed so they can be adequately cleaned and kept clean and in good repair.

    • Equipment - automated - QC check (21 CFR 111.30(c))

      Your quality control personnel did not periodically review routine calibrations, inspections and checks of your automated, mechanical, or electronic equipment.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Written procedure quality control operations material review (21 CFR 111.103)

      You did not establish written procedures for quality control operations for conducting a material review and making a disposition decision.

    • Identifying, holding - contamination, mix-ups (21 CFR 111.365(g))

      You did not identify and hold components and dietary supplements for which a material review and disposition decision is required in a manner that protects components and dietary supplements that are not under a material review against contamination and mix-ups with those that are under a material review.

    • Record - person document; time of performance (21 CFR 111.570(b)(2)(i))

      The person who performed a requirement relating to product complaints did not document, at the time of performance, that the requirement was performed.

    FEI 2432499

Show all 7 inspections
  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    11 citations posted:

    • Personnel - hygienic practices (21 CFR 111.10(b))
    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - contamination limits (21 CFR 111.70(b)(3))
    See all 11 citations
    • Personnel - hygienic practices (21 CFR 111.10(b))

      Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.

    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength and composition.

    • Specifications - contamination limits (21 CFR 111.70(b)(3))

      You did not establish limits for contamination that may adulterate or may lead to adulteration of the finished dietary supplement.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the strength of the finished dietary supplement.

    • Tests, examinations - scientifically valid (21 CFR 111.75(h))

      You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.

    • Master manufacturing record theoretical and expected yield (21 CFR 111.210(f))

      Your master manufacturing record did not include a statement of the theoretical yield for each point, step, or stage of the manufacturing process to ensure quality control.

    • Instructions; specifications; packaged, labeled (21 CFR 111.210(h)(1))

      The written instructions in your master manufacturing record did not include specifications for each point, step, or stage in the manufacturing process where control is necessary to ensure that the dietary supplement is packaged and labeled as specified in the master manufacturing record.

    • Master manufacturing record - sampling, tests, examinations (21 CFR 111.210(h)(2))

      The written instructions in your master manufacturing record did not include procedures for sampling and a cross-reference to procedures for tests or examinations.

    • Batch record - initials; each step (21 CFR 111.260(j)(2))

      Your batch production records did not include initials of the persons performing each step.

    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))

      You held components, dietary supplements and labels under conditions that lead to mix-up, contamination, or deterioration.

    FEI 2432499

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    1 citation posted:

    • Manufacturing operations - prevent contamination (21 CFR 111.365)
    Full citation text
    • Manufacturing operations - prevent contamination (21 CFR 111.365)

      You did not take necessary precautions during the manufacture of a dietary supplement to prevent contamination of dietary supplements.

    FEI 2432499

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    4 citations posted:

    • Documentation - equipment functions; intended use (21 CFR 111.35(b)(6))
    • Criteria for establishing specifications (21 CFR 111.315(a))
    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))
    • Record - person document; time of performance (21 CFR 111.570(b)(2)(i))
    Full citation text
    • Documentation - equipment functions; intended use (21 CFR 111.35(b)(6))

      You did not make and keep documentation of the controls you use to ensure that equipment functions according to its intended use.

    • Criteria for establishing specifications (21 CFR 111.315(a))

      You did not establish and follow laboratory control processes for use of criteria for establishing appropriate specifications.

    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))

      You held components under conditions that lead to mix-up, contamination, or deterioration.

    • Record - person document; time of performance (21 CFR 111.570(b)(2)(i))

      The person who performed a requirement relating to product complaints did not document, at the time of performance, that the requirement was performed.

    FEI 2432499

  • No action indicated · No objectionable conditions found

    Inspected

    Hauppauge, New York

    FEI 2432499

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    8 citations posted:

    • Gloves (21 CFR 111.10(b)(5))
    • Hand-washing facilities (21 CFR 111.15(i))
    • Floors, walls, ceilings (21 CFR 111.20(d)(1)(i))
    • Equipment - automated - QC check (21 CFR 111.30(c))
    See all 8 citations
    • Gloves (21 CFR 111.10(b)(5))

      Your personnel used gloves that were not in a sanitary condition.

    • Hand-washing facilities (21 CFR 111.15(i))

      Your hand-washing facilities are not adequate and are not convenient.

    • Floors, walls, ceilings (21 CFR 111.20(d)(1)(i))

      Your ceilings were not designed and constructed so they can be adequately cleaned and kept clean and in good repair.

    • Equipment - automated - QC check (21 CFR 111.30(c))

      Your quality control personnel did not periodically review routine calibrations, inspections and checks of your automated, mechanical, or electronic equipment.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Written procedure quality control operations material review (21 CFR 111.103)

      You did not establish written procedures for quality control operations for conducting a material review and making a disposition decision.

    • Identifying, holding - contamination, mix-ups (21 CFR 111.365(g))

      You did not identify and hold components and dietary supplements for which a material review and disposition decision is required in a manner that protects components and dietary supplements that are not under a material review against contamination and mix-ups with those that are under a material review.

    • Record - person document; time of performance (21 CFR 111.570(b)(2)(i))

      The person who performed a requirement relating to product complaints did not document, at the time of performance, that the requirement was performed.

    FEI 2432499

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    7 citations posted:

    • Specifications identity, purity strength, composition (21 CFR 111.70(c)(2))
    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
    • Specifications met - verify; finished batch (21 CFR 111.75(c))
    • Packaging description, representative label (21 CFR 111.210(g))
    See all 7 citations
    • Specifications identity, purity strength, composition (21 CFR 111.70(c)(2))

      You did not provide adequate documentation of your basis for why meeting the in-process specifications, in combination with meeting component specifications, will help ensure that the specifications are met for the identity, purity, strength, and composition.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength, and composition.

    • Packaging description, representative label (21 CFR 111.210(g))

      Your master manufacturing record did not include a description of the packaging and a representative label, or a cross-reference to the physical location of the actual or representative label.

    • Corrective action plans (21 CFR 111.210(h)(5))

      The written instructions in your master manufacturing did not include instructions for corrective action plans to use when specifications are not met.

    • Batch record - component; identity, weight (21 CFR 111.260(e))

      Your batch production records did not include the weight or measure of each component used.

    • Examination, testing; scientifically valid (21 CFR 111.320(b))

      You did not identify and use an appropriate scientifically valid method for each established specification for which testing or examination is required to determine whether the specification was met.

    FEI 2432499

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    3 citations posted:

    • Packaging description, representative label (21 CFR 111.210(g))
    • Corrective action plans (21 CFR 111.210(h)(5))
    • Examination, testing; scientifically valid (21 CFR 111.320(b))
    Full citation text
    • Packaging description, representative label (21 CFR 111.210(g))

      Your master manufacturing record did not include a description of the packaging and a representative label, or a cross-reference to the physical location of the actual or representative label.

    • Corrective action plans (21 CFR 111.210(h)(5))

      The written instructions in your master manufacturing did not include instructions for corrective action plans to use when specifications are not met.

    • Examination, testing; scientifically valid (21 CFR 111.320(b))

      You did not identify and use an appropriate scientifically valid method for each established specification for which testing or examination is required to determine whether the specification was met.

    FEI 2432499

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What we checked, and what we didn’t

Confirmed from public registry listings

Last checked

  • NSF/ANSI 455-2 GMP certification
  • USDA Organic certified operation
  • 4 facility addresses
  • Dosage forms in the certified scope
  • Operations listed for each facility
  • Product types on its USDA Organic certificate (organic items only)

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.

Ask about these in your quote request. How we verify

Other gummy manufacturers in the United States

  1. NSF lists 4 gummy facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a gummy facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists 2 gummy facilities, including one in St. Augustine, FL

    St. Augustine, FL, United Statesactivegummy.com

    • Gummies
    Operations:
    • Molding
    • Coating
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a gummy facility in Merrilville, IN

    Merrilville, IN, United Statesalbanesecandy.com

    • Gummies
    Operations:
    • Molding
    • Liquid formulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists a gummy facility in Miami, FL

    Miami, FL, United Statesalfavitamins.com

    • Capsules
    • Gummies
    • Liquids
    • Softgels
    • Tablets
    Operations:
    • Pasteurization
    • Coating
    • Liquid formulation
    • Tablet compression
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a gummy facility in Dallas, TX

    Dallas, TX, United Statesforeverliving.com

    • Gummies
    • Liquids
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Liquid formulation
    • Tablet compression
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026